Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Buys Two Shops to Bolster Maternal Health Play, Will Supply Screening Tools to Texas

NEW YORK (GenomeWeb News) – PerkinElmer has acquired NTD Laboratories and J.N. Macri Technologies for around $56.65 million, bringing the company closer to its goal of building a “screening and diagnostics capability in maternal health,” PerkinElmer said today.

Separately today, PerkinElmer said Texas has selected it to supply instruments and reagents for its enhanced newborn screening program.

 
J.N. Macri Technologies holds global patents related to free beta Human Chorionic Gonadotropin, a peptide hormone produced in the early stage of pregnancy that is “widely recognized as a critical biomarker for first-trimester prenatal risk assessment,” according to PerkinElmer.
 
NTD Laboratories, on the other hand, developed UltraScreen, a screening test that when used with ultrasound and maternal demographic data provides clinicians with a patient-specific risk probability for fetal abnormalities.
 
With these companies, PerkinElmer can develop screening and diagnostics capabilities in maternal health.
 
Meantime, under the multi-year agreement with Texas, PerkinElmer will supply the Texas Department of State Health Services Laboratory with tandem mass spectrometry systems, reagent kits, and software enhancements.
 
PerkinElmer has similar agreements with eight other states, including Alabama, California, Florida, Kentucky, Louisiana, Missouri, Pennsylvania and South Carolina.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.